Application of 3D Organoids Technology in Cancer Therapy

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 316

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Genetics, School of Medicine, Zhejiang University, Hangzhou 310058, China
Interests: organoid culture; cancer development; bioengineered organoid; high-throughput drug screening

Special Issue Information

Dear Colleagues,

Organoid technology has been established as a state-of-the-art cell culture tool that has emerged to efficiently reveal pathophysiologies and provide therapeutic options for human diseases. They recapitulate the in vivo morphology, heterogeneous cell types, genetic signatures, and functionality of original organs. Cancer organoids can be expanded long-term and genetically modified, which allows for extended applications in cancer research. The development of cancer patient-derived organoids potentially enables cancer modeling, translational medicine, and personalized therapeutics of various diseases.

Generation stage-changed organoids have the potential to reveal the differences in cell selection, specification, and cancer diversity. Heterogeneous aggregation of multiple distinct cell types is required to make functional organoids by developing co-culture systems incorporated with stroma, blood vessels, immune cells, etc. Innovative engineering approaches for organoids and tumor microenvironment production and organization are great tools for modeling cancer development. The establishment of patient-derived tumor organoid biobanks helps us to gain new insights into developing personalized medicine for patients. This Special Issue aims to gather recent advances in human cancer organoid biobanks, novel co-culture systems, and application cases of cancer organoids in pathological and therapeutic research in order to bring about new understanding and potential treatments of cancer.

Areas to be covered in this Special Issue may include, but are not limited to:

  • Establishment of cancer biobanks.
  • Development of novel co-culture system.
  • Use of engineered organoids for cancer modeling.
  • Application of organoids for mechanistic research of cancer development.
  • Use of organoids as cancer model systems for personalized therapy.
  • Use of organoids as high-throughput drug screening for cancer therapy.

We welcome original research, methods, and review articles.

Dr. Ming Jiang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Tumor organoids
  • Organoids biobank
  • Pathological mechanism
  • Cancer therapy
  • Drug screening
  • Personalized medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop